Security key
01438T106
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)
CUSIP: 01438T106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 59,794,743
- Total 13F shares
- 34,234,495
- Share change
- -3,268,716
- Total reported value
- $131,165,420
- Put/Call ratio
- 6.8%
- Price per share
- $3.83
- Number of holders
- 121
- Value change
- -$14,803,182
- Number of buys
- 68
- Number of sells
- 53
Report period
Q2 2025
Institutions
121
Top holders
10
ALDX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Aldeyra Therapeutics, Inc. SEC filings
Aldeyra Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 01438T106
Recent filing periods:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
3/4/5
|
Company · 10%+ Owner |
16%
|
9,275,851
|
$53,336,143 | — | 31 Mar 2025 | |
| Knoll Capital Management, LLC |
13F
|
Company |
9.2%
|
5,475,516
|
$31,484,217 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
6.2%
|
3,736,038
|
$21,482,219 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
3,718,018
|
$21,378,604 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.58%
|
348,521
|
$10,026,040 | — | 31 Mar 2025 | |
| ARDSLEY ADVISORY PARTNERS LP |
13F
|
Company |
2.9%
|
1,750,000
|
$9,888,200 | — | 31 Mar 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.1%
|
1,233,414
|
$7,092,130 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,137,828
|
$6,544,126 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
1,021,381
|
$5,872,941 | — | 31 Mar 2025 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.3%
|
779,000
|
$4,479,250 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.1%
|
669,850
|
$3,854,892 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.93%
|
555,059
|
$3,191,590 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.92%
|
551,091
|
$3,168,773 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.84%
|
501,137
|
$2,881,538 | — | 31 Mar 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.8%
|
476,000
|
$2,737,001 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.76%
|
451,915
|
$2,598,511 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.68%
|
408,542
|
$2,349,117 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.66%
|
392,555
|
$2,257,192 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.66%
|
392,532
|
$2,257,059 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.65%
|
389,582
|
$2,240,097 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.53%
|
314,423
|
$1,807,933 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.38%
|
225,465
|
$1,296,424 | — | 31 Mar 2025 | |
| WOODSTOCK CORP |
13F
|
Company |
0.37%
|
223,094
|
$1,282,790 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.35%
|
211,579
|
$1,216,579 | — | 31 Mar 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.3%
|
181,106
|
$1,041,360 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.3%
|
178,110
|
$1,024,132 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.27%
|
164,411
|
$945,363 | — | 31 Mar 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.26%
|
158,117
|
$909,173 | — | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.25%
|
151,642
|
$871,941 | — | 31 Mar 2025 | |
| Kennondale Capital Management LLC |
13F
|
Company |
0.25%
|
151,280
|
$869,860 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
137,985
|
$793,414 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
135,155
|
$777,141 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.21%
|
124,365
|
$715,099 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.2%
|
117,475
|
$675,481 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
116,600
|
$670,450 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
110,931
|
$637,853 | — | 31 Mar 2025 | |
| Bruce Greenberg |
3/4/5
|
Interim Chief Financial Officer |
—
mixed-class rows
|
378,662
mixed-class rows
|
$598,583 | — | 12 Aug 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.16%
|
95,960
|
$551,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
94,470
|
$543,203 | — | 31 Mar 2025 | |
| Joshua Reed |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
524,825
mixed-class rows
|
$478,196 | — | 30 Mar 2022 | |
| STRS OHIO |
13F
|
Company |
0.13%
|
76,500
|
$439,875 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.13%
|
75,476
|
$433,980 | — | 31 Mar 2025 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.12%
|
69,442
|
$399,292 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.11%
|
65,308
|
$375,521 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
58,650
|
$337,238 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
55,327
|
$318,130 | — | 31 Mar 2025 | |
| PFG Investments, LLC |
13F
|
Company |
0.09%
|
51,750
|
$297,563 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.09%
|
50,957
|
$293,004 | — | 31 Mar 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
50,454
|
$290,111 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.08%
|
49,268
|
$283,291 | — | 31 Mar 2025 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2025
As of 30 Jun 2025,
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,234,495 shares.
The largest 10 holders included
Knoll Capital Management, LLC, PERCEPTIVE ADVISORS LLC, BlackRock, Inc., VANGUARD GROUP INC, ARDSLEY ADVISORY PARTNERS LP, AQR CAPITAL MANAGEMENT LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, and STATE STREET CORP.
This page lists
120
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
124
Q2 2025 holders
121
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.